Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients. Irit Avivi , David H Vesole , Julio Davila-Valls , Lidia Usnarska-Zubkiewicz , Magdalena Olszewska-Szopa , Vibor Milunovic , Bartłomiej Baumert , Bogumiła Osękowska , Anna Kopińska , Massimo Gentile , Borja Puertas-Martinez , Paweł Robak , Edvan Crusoe , Luis Gerardo Rodriguez-Lobato , Małgorzata Gajewska , Gergely Varga , Michel Delforge , Yael Cohen , Alessandro Gozzetti , Camila Pena , Chaim Shustik , Gabor Mikala , Klara Zalac , H Denis Alexander , Peter Barth , Katja Weisel , Joaquín Martínez-López , Anna Waszczuk-Gajda , Mateusz Krzystański , Artur Jurczyszyn Cancers（2023）
摘要
With the continuing improvement in OS, a higher proportion of MM patients might develop SPM. The OS following SPM diagnosis is poor; hence, frequent surveillance and early detection are imperative to improve outcomes.
更多 查看译文
关键词
multiple myeloma, second primary malignancies developing
AI 理解论文
溯源树
样例
